190 related articles for article (PubMed ID: 38515580)
1. Experimental evidence for anti-metastatic actions of apigenin: a mini review.
Oh HM; Cho CK; Lee NH; Son CG
Front Oncol; 2024; 14():1380194. PubMed ID: 38515580
[TBL] [Abstract][Full Text] [Related]
2. Experimental Evidence for the Anti-Metastatic Action of Ginsenoside Rg3: A Systematic Review.
Oh HM; Cho CK; Son CG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012338
[TBL] [Abstract][Full Text] [Related]
3. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
4. Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer.
Ghauri MA; Su Q; Ullah A; Wang J; Sarwar A; Wu Q; Zhang D; Zhang Y
Phytomedicine; 2021 Apr; 84():153500. PubMed ID: 33626427
[TBL] [Abstract][Full Text] [Related]
5. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway.
Tong J; Shen Y; Zhang Z; Hu Y; Zhang X; Han L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967496
[TBL] [Abstract][Full Text] [Related]
6. Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.
Qin Y; Zhao D; Zhou HG; Wang XH; Zhong WL; Chen S; Gu WG; Wang W; Zhang CH; Liu YR; Liu HJ; Zhang Q; Guo YQ; Sun T; Yang C
Oncotarget; 2016 Jul; 7(27):41421-41431. PubMed ID: 27203387
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.
Ayaz M; Mosa OF; Nawaz A; Hamdoon AAE; Elkhalifa MEM; Sadiq A; Ullah F; Ahmed A; Kabra A; Khan H; Murthy HCA
Phytomedicine; 2024 Feb; 124():155272. PubMed ID: 38181530
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.
Cao HH; Chu JH; Kwan HY; Su T; Yu H; Cheng CY; Fu XQ; Guo H; Li T; Tse AK; Chou GX; Mo HB; Yu ZL
Sci Rep; 2016 Feb; 6():21731. PubMed ID: 26911838
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
11. Plant flavone apigenin: An emerging anticancer agent.
Shankar E; Goel A; Gupta K; Gupta S
Curr Pharmacol Rep; 2017 Dec; 3(6):423-446. PubMed ID: 29399439
[TBL] [Abstract][Full Text] [Related]
12. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells.
Lefort EC; Blay J
Clin Exp Metastasis; 2011 Apr; 28(4):337-49. PubMed ID: 21298326
[TBL] [Abstract][Full Text] [Related]
13. Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks.
Singh D; Khan MA; Siddique HR
Recent Pat Anticancer Drug Discov; 2019; 14(4):298-311. PubMed ID: 31746310
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells.
Chen YH; Wu JX; Yang SF; Yang CK; Chen TH; Hsiao YH
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406599
[TBL] [Abstract][Full Text] [Related]
15. Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells.
Kim CW; Hwang KA; Choi KC
Phytomedicine; 2016 Dec; 23(14):1787-1796. PubMed ID: 27912881
[TBL] [Abstract][Full Text] [Related]
16. Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives.
Salmani JMM; Zhang XP; Jacob JA; Chen BA
Chin J Nat Med; 2017 May; 15(5):321-329. PubMed ID: 28558867
[TBL] [Abstract][Full Text] [Related]
17. Could inhibition of metalloproteinases be used to block the process of metastasis?
Alba J; Barcia R; Gutiérrez-Berzal J; Ramos-Martínez JI
Cell Biochem Funct; 2022 Aug; 40(6):600-607. PubMed ID: 35789101
[TBL] [Abstract][Full Text] [Related]
18. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
19. Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells.
Yu D; Ye T; Xiang Y; Shi Z; Zhang J; Lou B; Zhang F; Chen B; Zhou M
Onco Targets Ther; 2017; 10():4719-4729. PubMed ID: 29026320
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
